Kipk,,,,,,,,,nope,,,,,,,I agree with BDAZ on what he wrote earlier here. And when we had to include Lipitor we all let out a big sign in disbelief at the time. The trial design was adjusted by the FDA and DMcC noted they would have to comply. Because epigenetics was cutting edge science was pointed out as being one of the reasons for inclusion of both statins if memory serves me. And possibly imo RVX being a junior face at the FDA round table. If a Merk or Pfizer partner was present at the time then maybe the FDA could have been swayed,,maybe!